JDRF Centers bring together projects linked by a central theme with the aim of testing a clinical outcome during the life of the center. JDRF places special value on proposals that uniquely bring together researchers from diverse but relevant fields to develop innovative approaches for treatment and prevention of type 1 Diabetes and its complications. Currently, JDRF supports the following centers in each program area:
Beta Cell Therapies:
- JDRF Center for Beta Cell Therapy in Diabetes
- JDRF Center for Islet Transplantation at the University of Miami
- JDRF Clinical Center for Human Islet Cell Transplantation at the University of Alberta
- The JDRF Center for Islet Transplantation at the University of California, San Francisco
- JDRF Center for Islet Transplantation at Minnesota
- The JDRF-Penn Comprehensive Islet Transplantation Program
- JDRF Center for Islet Transplantation in the Nordic Countries
- JDRF Center for Islet Transplantation at the City of Hope
- JDRF Center at Emory University
Immune Therapies:
JDRF Autoimmunity Center Consortium (ACC):
- JDRF-Harvard Center for Immunological Tolerance in T1D
- BDC JDRF Autoimmunity Prevention Center
- Benaroya Diabetes Center
- JDRF Collaborative Center for Cell Therapy
- JDRF UK Centre for Diabetes Genes, Autoimmunity and Prevention (D-GAP)
- Cord Blood Therapies for Type 1 Diabetes
- JDRF Center for Developing Immune Therapies for Type 1 Diabetes
- JDRF/ Wellcome Trust Diabetes and Inflammation Laboratory
Complications Therapies:
- JDRF Center for the Study of Complications in Diabetes at Albert Einstein College of Medicine / University of Heidelberg / Baker International Diabetes Institute
- JDRF Center for the Study of Complications in Diabetes at the University of Michigan